Insider Transactions in Q2 2023 at Cytokinetics Inc (CYTK)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 12
2023
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
12,500
-2.75%
|
$462,500
$37.06 P/Share
|
|
Jun 12
2023
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+2.68%
|
$112,500
$9.65 P/Share
|
|
Jun 08
2023
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
2,500
-1.51%
|
$95,000
$38.07 P/Share
|
|
May 31
2023
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
12,500
-2.76%
|
$462,500
$37.67 P/Share
|
|
May 31
2023
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+2.68%
|
$112,500
$9.65 P/Share
|
|
May 16
2023
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
12,500
-2.76%
|
$462,500
$37.41 P/Share
|
|
May 16
2023
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+2.68%
|
$112,500
$9.65 P/Share
|
|
May 15
2023
|
John T Henderson Director |
SELL
Open market or private sale
|
Direct |
4,166
-14.08%
|
$154,142
$37.77 P/Share
|
|
May 15
2023
|
John T Henderson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,166
+12.34%
|
$24,996
$6.78 P/Share
|
|
May 11
2023
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
1,787
-1.07%
|
$69,693
$39.5 P/Share
|
|
May 10
2023
|
Sandford D Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+21.9%
|
-
|
|
May 10
2023
|
Wendall Wierenga Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+21.9%
|
-
|
|
May 10
2023
|
Nancy Wysenski Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+23.07%
|
-
|
|
May 10
2023
|
B Lynne Parshall Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+25.0%
|
-
|
|
May 10
2023
|
Edward M. Md Kaye Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+21.42%
|
-
|
|
May 10
2023
|
John T Henderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+14.12%
|
-
|
|
May 10
2023
|
Robert Arthur Harrington Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+32.15%
|
-
|
|
May 10
2023
|
Santo J Costa Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+25.0%
|
-
|
|
May 10
2023
|
Muna Bhanji Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+23.77%
|
-
|
|
May 03
2023
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
7,000
-4.02%
|
$280,000
$40.0 P/Share
|
|
May 03
2023
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+3.86%
|
$49,000
$7.96 P/Share
|
|
Apr 28
2023
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
12,500
-2.76%
|
$462,500
$37.68 P/Share
|
|
Apr 28
2023
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+2.68%
|
$112,500
$9.65 P/Share
|
|
Apr 14
2023
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
12,500
-2.76%
|
$437,500
$35.61 P/Share
|
|
Apr 14
2023
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+2.68%
|
$112,500
$9.65 P/Share
|
|
Apr 13
2023
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
4,000
-2.34%
|
$136,000
$34.21 P/Share
|
|
Apr 03
2023
|
John T Henderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
530
+2.04%
|
$19,610
$37.71 P/Share
|
|
Apr 03
2023
|
Robert Arthur Harrington Director |
BUY
Grant, award, or other acquisition
|
Direct |
298
+5.09%
|
$11,026
$37.71 P/Share
|
|
Apr 03
2023
|
Sandford D Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
298
+2.27%
|
$11,026
$37.71 P/Share
|
|
Apr 03
2023
|
Edward M. Md Kaye Director |
BUY
Grant, award, or other acquisition
|
Direct |
298
+2.18%
|
$11,026
$37.71 P/Share
|
|
Apr 03
2023
|
Nancy Wysenski Director |
BUY
Grant, award, or other acquisition
|
Direct |
149
+1.26%
|
$5,513
$37.71 P/Share
|
|
Apr 03
2023
|
Wendall Wierenga Director |
BUY
Grant, award, or other acquisition
|
Direct |
298
+2.27%
|
$11,026
$37.71 P/Share
|